Attomarker

Attomarker is a nano-photonic biochemical testing company operating in the personalized healthcare market, focusing on four global epidemics: COVID-19, obesity, food allergies, and antimicrobial resistance (AMR). The company has developed a technology that measures multiple biomarkers in blood and saliva, providing a profile of up to 20 tests within 7 minutes. This data can be used to determine personalized patient healthcare pathways across multiple healthcare settings including bedside, operating room, pharmacy, and home.